A citation-based method for searching scientific literature

Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito. Diabetes Care 2018
Times Cited: 5







List of co-cited articles
16 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control.
Steven V Edelman, William H Polonsky. Diabetes Care 2017
145
80

Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013.
Kasia J Lipska, Xiaoxi Yao, Jeph Herrin, Rozalina G McCoy, Joseph S Ross, Michael A Steinman, Silvio E Inzucchi, Thomas M Gill, Harlan M Krumholz, Nilay D Shah. Diabetes Care 2017
177
80

Glycemic control in type 2 diabetes: from medication nonadherence to residual vascular risk.
Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito. Endocrine 2018
20
60

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
60

Clinical inertia as a clinical safeguard.
Dario Giugliano, Katherine Esposito. JAMA 2011
58
60

Potential overtreatment of diabetes mellitus in older adults with tight glycemic control.
Kasia J Lipska, Joseph S Ross, Yinghui Miao, Nilay D Shah, Sei J Lee, Michael A Steinman. JAMA Intern Med 2015
233
60


CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.
Alan J Garber, Martin J Abrahamson, Joshua I Barzilay, Lawrence Blonde, Zachary T Bloomgarden, Michael A Bush, Samuel Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Vivian A Fonseca,[...]. Endocr Pract 2018
292
40

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
40

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians.
Amir Qaseem, Michael J Barry, Linda L Humphrey, Mary Ann Forciea, Nick Fitterman, Carrie Horwitch, Devan Kansagara, Robert M McLean, Timothy J Wilt. Ann Intern Med 2017
114
40

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
40

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
40

Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases.
Marsha A Raebel, Julie Schmittdiel, Andrew J Karter, Jennifer L Konieczny, John F Steiner. Med Care 2013
271
40

Adherence to diabetes medication: a systematic review.
I Krass, P Schieback, T Dhippayom. Diabet Med 2015
202
40

Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study.
Jason Gordon, Phil McEwan, Iskandar Idris, Marc Evans, Jorge Puelles. BMJ Open Diabetes Res Care 2018
23
40

Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians.
Amir Qaseem, Timothy J Wilt, Devan Kansagara, Carrie Horwitch, Michael J Barry, Mary Ann Forciea, Nick Fitterman, Kate Balzer, Cynthia Boyd, Linda L Humphrey,[...]. Ann Intern Med 2018
195
40

New markers of insulin resistance in polycystic ovary syndrome.
K Polak, A Czyzyk, T Simoncini, B Meczekalski. J Endocrinol Invest 2017
89
20

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn,[...]. N Engl J Med 2015
20


Diabetes is a cardiovascular disease, isn't it?
Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito. Diabetes Res Clin Pract 2018
6
20

Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study.
Mikhail Kosiborod, Kåre I Birkeland, Matthew A Cavender, Alex Z Fu, John P Wilding, Kamlesh Khunti, Reinhard W Holl, Anna Norhammar, Marit E Jørgensen, Eric T Wittbrodt,[...]. Diabetes Obes Metab 2018
54
20



6. Glycemic Targets.
. Diabetes Care 2017
225
20

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
20


Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Rury R Holman, M Angelyn Bethel, Robert J Mentz, Vivian P Thompson, Yuliya Lokhnygina, John B Buse, Juliana C Chan, Jasmine Choi, Stephanie M Gustavson, Nayyar Iqbal,[...]. N Engl J Med 2017
918
20

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
William B White, Christopher P Cannon, Simon R Heller, Steven E Nissen, Richard M Bergenstal, George L Bakris, Alfonso T Perez, Penny R Fleck, Cyrus R Mehta, Stuart Kupfer,[...]. N Engl J Med 2013
20

Type 2 diabetes and cardiovascular prevention: the dogmas disputed.
Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito. Endocrine 2018
7
20


Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Marc A Pfeffer, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Hertzel C Gerstein, Lars V Køber, Francesca C Lawson, Lin Ping, Xiaodan Wei, Eldrin F Lewis,[...]. N Engl J Med 2015
20

Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review.
Kamlesh Khunti, Marilia B Gomes, Stuart Pocock, Marina V Shestakova, Stéphane Pintat, Peter Fenici, Niklas Hammar, Jesús Medina. Diabetes Obes Metab 2018
131
20


Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus.
G Reach, V Pechtner, R Gentilella, A Corcos, A Ceriello. Diabetes Metab 2017
102
20

Intensive glucose control and macrovascular outcomes in type 2 diabetes.
F M Turnbull, C Abraira, R J Anderson, R P Byington, J P Chalmers, W C Duckworth, G W Evans, H C Gerstein, R R Holman, T E Moritz,[...]. Diabetologia 2009
780
20

Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data Set.
Kevin M Pantalone, Anita D Misra-Hebert, Todd M Hobbs, Xinge Ji, Sheldon X Kong, Alex Milinovich, Wayne Weng, Janine Bauman, Rahul Ganguly, Bartolome Burguera,[...]. Diabetes Care 2018
36
20

Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials.
Sophia Zoungas, Hisatomi Arima, Hertzel C Gerstein, Rury R Holman, Mark Woodward, Peter Reaven, Rodney A Hayward, Timothy Craven, Ruth L Coleman, John Chalmers. Lancet Diabetes Endocrinol 2017
218
20

Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System.
Kevin M Pantalone, Brian J Wells, Kevin M Chagin, Flavia Ejzykowicz, Changhong Yu, Alex Milinovich, Janine M Bauman, Michael W Kattan, Swapnil Rajpathak, Robert S Zimmerman. Diabetes Care 2016
40
20

Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians?
Baiju R Shah, Janet E Hux, Andreas Laupacis, Bernard Zinman, Carl van Walraven. Diabetes Care 2005
272
20

Predictors of Quality of Life and Other Patient-Reported Outcomes in the PANORAMA Multinational Study of People With Type 2 Diabetes.
Clare Bradley, Eveline Eschwège, Pedro de Pablos-Velasco, Klaus G Parhofer, Dominique Simon, Hans Vandenberghe, Linda Gönder-Frederick. Diabetes Care 2018
47
20

Cost sharing, adherence, and health outcomes in patients with diabetes.
Teresa B Gibson, Xue Song, Berhanu Alemayehu, Sara S Wang, Jessica L Waddell, Jonathan R Bouchard, Felicia Forma. Am J Manag Care 2010
95
20

Pharmacist-Led Self-management Interventions to Improve Diabetes Outcomes. A Systematic Literature Review and Meta-Analysis.
Linda van Eikenhorst, Katja Taxis, Liset van Dijk, Han de Gier. Front Pharmacol 2017
48
20

Medication intensification in diabetes in rural primary care: a cluster-randomised effectiveness trial.
Katherine L Billue, Monika M Safford, Amanda H Salanitro, Thomas K Houston, William Curry, Yongin Kim, Jeroan J Allison, Carlos A Estrada. BMJ Open 2012
11
20

A systematic literature review comparing methods for the measurement of patient persistence and adherence.
Carol A Forbes, Sohan Deshpande, Francesc Sorio-Vilela, Lucie Kutikova, Steven Duffy, Ioanna Gouni-Berthold, Emil Hagström. Curr Med Res Opin 2018
53
20

Association Between Adherence to Pharmacotherapy and Outcomes in Type 2 Diabetes: A Meta-analysis.
Kamlesh Khunti, Samuel Seidu, Setor Kunutsor, Melanie Davies. Diabetes Care 2017
71
20

Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study.
Pedro de Pablos-Velasco, Klaus G Parhofer, Clare Bradley, Eveline Eschwège, Linda Gönder-Frederick, Pierre Maheux, Ian Wood, Dominique Simon. Clin Endocrinol (Oxf) 2014
113
20

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
20


Medication nonadherence: a diagnosable and treatable medical condition.
Zachary A Marcum, Mary Ann Sevick, Steven M Handler. JAMA 2013
112
20

Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial.
John Furler, David O'Neal, Jane Speight, Jo-Anne Manski-Nankervis, Alexandra Gorelik, Elizabeth Holmes-Truscott, Louise Ginnivan, Doris Young, James Best, Elizabeth Patterson,[...]. BMJ 2017
27
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.